Pfizer's ex-R&D chief Dolsten withdraws from Novo Nordisk board race

Mikael Dolsten, Pfizer's former research and development chief, has withdrawn his candidacy for Novo Nordisk's board, citing personal reasons, the Danish drugmaker said on Thursday. ...